Answers are grounded in this paper and cite their sources.
Study improved beta cell function with empagliflozin compared to insulin in type 2 diabetes patients, suggesting metabolic benefits beyond glucose relief.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Thirumathyam et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: